Computational and experimental study on the interaction of three novel rare earth complexes containing 2,9-dimethyl-1,10-phenanthroline with human serum albumin

In this paper, several rare earth terbium(III), ytterbium(III) and yttrium(III)] complexes containing 2,9-dimethyl-1,10-phenanthroline (Me₂Phen) were successfully synthesized and characterized by means of elemental analysis (CHN), infrared spectroscopy (FT-IR), UV–vis absorption spectroscopy and ¹HNMR. To explore the potential medicinal value of these complexes (MMe₂Phen), their binding interactions with human serum albumin (HSA) were investigated through UV–vis and fluorescence spectroscopies and also molecular docking examinations. The thermodynamic parameters, binding forces and Förster resonance distance between these complexes and Trp-214 of HSA were estimated from the analysis of fluorescence measurements. The values of estimated binding constants (K_b) ranging for the formation of MMe₂Phen:HSA complex were in the order of 10⁵ M^?1. The thermodynamic parameters determined by van’t Hoff analysis of K_b (ΔH°?<?0 and ΔS°?<?0) clearly indicate the major rules of hydrogen bonds and van der Waals interactions in the formation process of MMe₂Phen:HSA. The values of Stern–Volmer constant and the evaluation of dynamic quenching constant at various temperatures provided good evidences for static quenching mechanism. Furthermore, the results of molecular docking calculation and competitive binding experiments represent the binding of these complexes to site 3 of HSA located in subdomain IB, containing both polar and apolar residues. The consistency of computational and experimental results, according to the binding sites and the order of binding affinities (TbMe₂Phen?>?YbMe₂Phen?>?YMe₂Phen), supports the accuracy of docking calculation.